Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer. | Biol Direct | 2022 | 36319976 | PubTator, text mining | PubMed |
| Identification of Differentially Expressed Genes Associated with the Prognosis and Diagnosis of Hepatocellular Carcinoma by Integrated Bioinformatics Analysis. | Biomed Res Int | 2022 | 36317111 | PubTator, text mining | PubMed |
| Personalized targeted therapy prescription in colorectal cancer using algorithmic analysis of RNA sequencing data. | BMC Cancer | 2022 | 36316649 | PubTator, text mining | PubMed |
| Overcoming therapeutic resistance to platinum-based drugs by targeting Epithelial-Mesenchymal transition. | Front Oncol | 2022 | 36313710 | PubTator, text mining | PubMed |
| In silico characterization of competing endogenous RNA network in glioblastoma multiforme with a systems biology approach. | Front Oncol | 2022 | 36313669 | PubTator, text mining | PubMed |
| Increased Aurora B expression reduces substrate phosphorylation and induces chromosomal instability. | Front Cell Dev Biol | 2022 | 36313574 | PubTator, text mining | PubMed |
| A genomic and transcriptomic study toward breast cancer. | Front Genet | 2022 | 36313438 | PubTator, text mining | PubMed |
| Deep transfer learning of cancer drug responses by integrating bulk and single-cell RNA-seq data. | Nat Commun | 2022 | 36310235 | PubTator, text mining | PubMed |
| ASPM May be Related to the Malignant Progression of Hepatitis B and is Associated With a Poor Prognosis of Hepatocellular Carcinoma. | Front Bioinform | 2022 | 36304312 | PubTator, text mining | PubMed |
| Bioinformatic Deconstruction of Differentially Expressed Sequence Tags in Hepatocellular Carcinoma Based on Artificial Neural Network. | Contrast Media Mol Imaging | 2022 | 36299828 | PubTator, text mining | PubMed |
| Viral Agents as Potential Drivers of Diffuse Large B-Cell Lymphoma Tumorigenesis. | Viruses | 2022 | 36298660 | PubTator, text mining | PubMed |
| KAT2A/E2F1 Promotes Cell Proliferation and Migration via Upregulating the Expression of UBE2C in Pan-Cancer. | Genes (Basel) | 2022 | 36292703 | PubTator, text mining | PubMed |
| Juxtaposition of Bub1 and Cdc20 on phosphorylated Mad1 during catalytic mitotic checkpoint complex assembly. | Nat Commun | 2022 | 36289199 | PubTator, text mining | PubMed |
| Identification of prognostic genes for early basal-like breast cancer with weighted gene co-expression network analysis. | Medicine (Baltimore) | 2022 | 36281185 | PubTator, text mining | PubMed |
| Nanomaterial-assisted CRISPR gene-engineering - A hallmark for triple-negative breast cancer therapeutics advancement. | Mater Today Bio | 2022 | 36267139 | PubTator, text mining | PubMed |
| Identification of the Key Genes Involved in the Tumorigenesis and Prognosis of Prostate Cancer. | Comput Math Methods Med | 2022 | 36245843 | PubTator, text mining | PubMed |
| The SNHG1-Centered ceRNA Network Regulates Cell Cycle and Is a Potential Prognostic Biomarker for Hepatocellular Carcinoma. | Tohoku J Exp Med | 2022 | 36244757 | PubTator, text mining | PubMed |
| Identification of core genes as potential biomarkers for predicting progression and prognosis in glioblastoma. | Front Genet | 2022 | 36238156 | PubTator, text mining | PubMed |
| Editorial: E3 ubiquitin ligases: From structure to physiology to therapeutics, Volume II. | Front Physiol | 2022 | 36237534 | PubTator, text mining | PubMed |
| bub1 as a potential oncogene and a prognostic biomarker for neuroblastoma. | Front Oncol | 2022 | 36237324 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=28